Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
{{output}}
Hormone receptor-positive (HR+) breast cancer (BC) accounts for approximately 70% of all breast invasive tumors. Endocrine therapy (ET) represents the standard treatment for HR + BC. Most patients, however, eventually develop resistance to ET, which limits the... ...
